Frequently Asked Questions

Find on this page the main answers to questions you might ask yourself about Theraclion:


+On which market is Theraclion listed?
Theraclion is listed on Alternext Paris

+How to become a Theraclion shareholder?
You can buy Theraclion shares from your financial intermediary / institution, indicating if needed the following identification codes:

ISIN code: FR0010120402 – Ticker: ALTHE

+Are Theraclion shares eligible for a Savings Plan in Shares (“Plan Epargne Actions” or “PEA”)?
Yes, Theraclion is a French company. Theraclion shares may be held in a Savings Plan in shares (” PEA “).

+Are Theraclion shares eligible for PEA- SME (french for Savings Plan in SME’s shares)?
Yes, Theraclion meets the eligibility criteria of the tax system “PEA –SME” namely i / be a company of less than 5,000 employees and ii / have a turnover of less than EUR 1,500 million or a total balance sheet less than 2,000 million euros, Theraclion shares may be held in a savings plan in shares for the financing of small and medium enterprises and medium-sized companies (PEA / SMEs).

+What does Theraclion?
Theraclion is a French company specialized in high technology medical equipment, which has developed an innovative solution of echotherapy, the Echopulse® for the non-invasive treatment of benign thyroid nodules and breast fibroadenomas.
The Echopulse ® combines in one machine an ultrasound system to identify the target tumor and a treatment system for the non- invasive ablation of tumors without scars.
This solution now provides a real alternative to surgery and minimally invasive techniques.